Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Trial of YYC506 in Complex Dyslipidemia
NCT04858308Phase 3Unknown
- Sponsor
- Yooyoung Pharmaceutical
- Start
- Jan 2021
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atorvastatin, fenofibrate in dyslipidemia, sponsored by Yooyoung Pharmaceutical. Status: unknown.
02
Drugs
atorvastatinfenofibrate
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT04858308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04858308.